MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management

Activity Resources

Booklet
Activity Information
Meet the faculty, learn more about what expert faculty will be discussing, or review accreditation information.
Download
Slides
Download the Presentation
Review the information presented during the activity.
Download
Credit
Apply for credit
Gain valuable CME/CE credit for your participation in today's activity.
Claim Credit
Resource
Bibliography and Suggested Reading
Bibliography and suggested reading for MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management.
Download

Supported through independent educational grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.